RESUMO
Data regarding the treatment of childhood granulomatous periorificial dermatitis (CGPD) using oral therapies are limited. This study included 31 Chinese children with CGPD treated with oral roxithromycin. After 12 weeks of treatment, 90.3% of the patients recovered, and there were no severe adverse effects. Our results suggest that oral roxithromycin is an effective and safe treatment for CGPD.
Assuntos
Dermatite Perioral , Úlceras Orais , Roxitromicina , Criança , Humanos , Dermatite Perioral/tratamento farmacológico , População do Leste Asiático , Granuloma , Úlceras Orais/tratamento farmacológico , Roxitromicina/uso terapêuticoRESUMO
Canine periocular dermatitis may be associated with excessive facial folds and heavy brows (EFF-HB). There is no gold standard therapy for EFF-HB-associated periocular dermatitis, and conventional medical management may fail. Herein, we describe periocular fluorescence photobiomodulation and rhytidectomy as novel approaches to treat EFF-HB-associated periocular dermatitis refractory to medical management.
La dermatite périoculaire canine peut être associée à des plis faciaux prononcés et à des sourcils épais (EFF-HB). Il n'y a pas de traitement de référence de la dermatite périoculaire associée à l'EFF-HB, et la prise en charge médicale conventionnelle peut échouer. Ici, nous décrivons la photobiomodulation par fluorescence périoculaire et la rhytidectomie comme de nouvelles approches pour traiter la dermatite périoculaire associée à l'EFF-HB réfractaire à la prise en charge médicale.
La dermatitis periocular canina puede estar asociada con pliegues faciales excesivos y cejas densas (EFF-HB). No existe una terapia estándar para la dermatitis periocular asociada a EFF-HB, y el tratamiento médico convencional puede fallar. En este artículo describimos el uso de fotobiomodulación periocular de fluorescencia y ritidectomía como nuevas terapias para tratar la dermatitis periocular asociada a EFF-HB refractaria al tratamiento médico habitual.
A dermatite periocular canina pode estar associada a dobras faciais excessivas e sobrancelhas pesadas (EFF-HB). Não há nenhuma terapia de padrão ouro para dermatite periocular associada a EFF-HB, e os tratamentos clínicos convencionais podem falhar. Neste trabalho, nós descrevemos a fotobiomodulação fluorescente periocular e a retidectomia como novas abordagens para o tratamento de dermatite periocular associada a EFF-HB refratária ao tratamento medicamentoso.
Assuntos
Dermatite Perioral , Doenças do Cão , Ritidoplastia , Animais , Cães , Dermatite Perioral/veterinária , Ritidoplastia/veterinária , Fluorescência , Doenças do Cão/radioterapia , Doenças do Cão/cirurgiaAssuntos
Dermatite Perioral , Dermatite , Exantema , Criança , Doxiciclina/uso terapêutico , HumanosRESUMO
The influence of nutrition on the pathophysiology and clinical severity of inflammatory facial dermatoses such as acne, rosacea, seborrheic dermatitis, and perioral dermatitis has been controversially discussed for years. As part of a modern treatment approach, clinicians should provide patients with information on how their choice of diet might impact their dermatologic diagnosis and could potentially enhance therapeutic outcome. Recently, the concept of a gut-skin axis has gained momentum in the understanding of inflammatory dermatoses, with nutrition considered a contributing factor in this context. For example, gastrointestinal symptoms in rosacea patients may indicate a dysbiosis of the gut microbiome, treatment of which may also improve severity of the skin disease. New research efforts were recently made for acne patients addressing the clinical effects of omega-3 fatty acids and probiotics. In contrast, due to the limited data available, no comparable specific dietary recommendations can yet be made for seborrheic or perioral dermatitis. However, there are promising signs that clinical nutrition and dermatology will be more extensively interlinked in the future, both clinically and scientifically.
Assuntos
Acne Vulgar , Dermatite Perioral , Dermatoses Faciais , Rosácea , Dermatopatias , Acne Vulgar/terapia , Humanos , Rosácea/diagnóstico , Rosácea/tratamento farmacológico , Pele , Dermatopatias/diagnóstico , Dermatopatias/terapiaRESUMO
RESUMEN Fundamento: El carcinoma basocelular periocular es una lesión tumoral que surge de las células basales de la epidermis y los folículos pilosos, con un alto potencial de destrucción local, pueden ser desfigurantes e invaden el tejido que los rodea dando lugar a deformidades o pérdida de la función del órgano afectado. En orden de aparición es más común en el párpado inferior, el canto medial, el párpado superior y el canto temporal. Objetivo: Describir los resultados de la aplicación del HeberFERON en una serie de casos con carcinoma basocelular periocular que acudieron a consulta de dermatología del Policlínico Centro, de enero de 2017 a diciembre del 2020. Metodología: Se realizó un estudio de serie de casos clínicos con carcinoma basocelular periocular que acudieron a la consulta de dermatología del Policlínico Centro. Se incluyeron 17 casos con diagnóstico clínico, dermatoscópico e histopatológico. Se realizó una evaluación inicial, durante y 16 semanas después del tratamiento; se administró 10.5 UI de HeberFERON 3 veces por semana perilesional e intradérmica hasta completar 9 dosis. Las variables principales fueron la respuesta al tratamiento y la presencia o no de eventos adversos. Resultados: Predominó el sexo masculino, el fototipocutáneo II, la localización en párpado inferior, el subtipo clínico nódulo ulcerativo y el histológico sólido, se logró respuesta completa en la mayoría de los pacientes. Como eventos adversos se presentaron dolor en el sitio de inyección, fiebre, mal estar general, edema y eritema perilesional. Conclusiones: La respuesta al tratamiento fue favorable en la mayoría de los pacientes tratados con HeberFERON.
ABSTRACT Background: Periocular basal cell carcinoma is a tumor lesion arising from the epidermis and hair follicles basal cells, with a high potential local destruction, can be disfiguring and invade the surrounding tissue leading to deformities or loss of function of the affected organ. In order of appearance it is most common in the lower eyelid, medial edge, upper eyelid and temporal edge. Objective: To describe the results of the application of HeberFERON in a case series with periocular basal cell carcinoma who attended dermatology appointment at the Policlínico Centro, from January 2017 to December 2020. Methodology: A series study of clinical cases with periocular basal cell carcinoma who attended the dermatology appointment at the Policlínico Centro was conducted. 17 cases with clinical, dermatoscopic and histopathological diagnosis were included. A baseline evaluation was conducted, during and 16 weeks after treatment; 10.5 IU of HeberFERON was administered 3 times a week perilesional and intradermally until completing 9 doses. The main variables were the treatment response and the presence or absence of adverse events. Results: Male sex, phototypocutaneous II, lower eyelid location, clinical subtype ulcerative nodule and solid histological subtype predominated, complete response was achieved in most patients. Adverse events were pain at the injection site, fever, general malaise, edema and perilesional erythema. Conclusions: Treatment response was favorable in most patients treated with HeberFERON.
Assuntos
Neoplasias Cutâneas/terapia , Carcinoma Basocelular/terapia , Interferon alfa-2/uso terapêutico , Dermatite Perioral/terapiaRESUMO
BACKGROUND AND AIMS: Perioral dermatitis is a common cutaneous condition characterized by acneiform facial eruptions often with an eczematous appearance. A granulomatous subtype exists in addition to the classic variant. While topical corticosteroids have been largely implicated in this condition, its etiology is not completely understood. METHODS: Using the keywords "corticosteroids," "dermatology," "fusobacteria," "perioral dermatitis," and "periorificial dermatitis," we searched the databases PubMed, MEDLINE, and EMBASE to find the relevant literature. Only articles in English were chosen. The level of evidence was evaluated and selected according to the highest level working our way downwards using the Oxford Centre of Evidence-Based Medicine 2011 guidance. RESULTS: This systematic review found the strongest evidence to support topical corticosteroid misuse as the principal causative factor in the pathogenesis of perioral dermatitis. CONCLUSION: In terms of treatment, further research is required to robustly investigate promising treatment options including tetracyclines, topical metronidazole, topical azelaic acid, adapalene gel, and oral isotretinoin.
Assuntos
Dermatite Perioral , Fármacos Dermatológicos , Antibacterianos/uso terapêutico , Dermatite Perioral/diagnóstico , Dermatite Perioral/tratamento farmacológico , Dermatite Perioral/etiologia , Fármacos Dermatológicos/uso terapêutico , Humanos , Isotretinoína , Metronidazol/uso terapêuticoRESUMO
La dermatitis periorificial, es una erupción acneiforme que comúnmente afecta la región perioral y con frecuencia se extiende alrededor de la nariz y los ojos. Los mayores reportes son en mujeres de 20 a 45 años y en menor proporción en menores de 18 años. Su etiología es desconocida, pero se ha asociado al uso de glucocorticoides tópicos, inhalados y sistémicos. Objetivo: presentar una serie de casos de dermatititis periorificial, asociados con el uso indiscriminado de glucocorticoides, que respondieron eficazmente al tratamiento con metronidazol tópico, solo o combinado con doxiciclina. Presentación de casos clínicos: se describen cinco pacientes de sexo femenino, edades comprendidas entre 4 y 18 años, atendidos en la consulta ambulatoria de Dermatología. En cuatro casos, se documentó el uso prolongado de glucocorticoides tópicos/inhalados, de estos, tres presentaron lesiones papulares eritematosas o color piel, escasas pústulas, asintomáticas o prurito leve, localizadas a nivel perioral, perinasal y periocular; perioral y perinasal en uno y solamente perioral en otro. El tratamiento con metronidazol tópico fue exitoso en los cinco pacientes y en uno se combinó con doxiciclina oral. Conclusiones: el manejo de la dermatitis periorificial puede responder eficazmente al metronidazol tópico y dada su asociación al uso de glucocorticoides, se recomienda evitar el uso injustificado y prolongado de los mismos, tanto en forma tópica como inhalada o sistémica...(AU)
Assuntos
Humanos , Feminino , Pré-Escolar , Adolescente , Dermatite Perioral , Glucocorticoides , Dermatite Atópica , Metronidazol/uso terapêuticoRESUMO
Granulomatous diseases are chronic inflammatory disorders whose pathogenesis is triggered by an array of infectious and noninfectious agents, and may be localized or a manifestation of systemic, disseminated disease. As in the skin, oral manifestations of granulomatous inflammation are often nonspecific in their clinical appearance. Thus, in the absence of overt foreign material or a recognizable infectious agent, identifying the underlying cause of the inflammation can be challenging. This article highlights various conditions known to induce granulomatous inflammation within the oral soft tissues.
Assuntos
Doença de Crohn/complicações , Granuloma/etiologia , Granuloma/patologia , Doenças da Boca/etiologia , Doença de Crohn/diagnóstico , Dermatite Perioral/etiologia , Dermatite Perioral/patologia , Granuloma de Corpo Estranho/patologia , Granulomatose com Poliangiite/complicações , Granulomatose com Poliangiite/diagnóstico , Granulomatose Orofacial/diagnóstico , Granulomatose Orofacial/terapia , Histoplasmose/complicações , Humanos , Doenças da Boca/patologia , Sarcoidose/complicações , Sarcoidose/diagnóstico , Sífilis/complicações , Tuberculose Bucal/complicações , Tuberculose Bucal/diagnósticoAssuntos
Blefaroplastia , Doenças Palpebrais/diagnóstico , Doenças Palpebrais/terapia , Técnicas Cosméticas , Preenchedores Dérmicos/uso terapêutico , Dermatite Alérgica de Contato/diagnóstico , Dermatite Perioral/diagnóstico , Diagnóstico Diferencial , Humanos , Aparelho Lacrimal , Linfedema/diagnóstico , Prolapso , Rosácea/diagnóstico , Doenças da Glândula Tireoide/diagnóstico , Testes de Campo Visual , Campos VisuaisRESUMO
Face and neck dermatitis in the atopic dermatitis patient is a diagnostically challenging entity with broad differential diagnoses. Recent case reports reporting face and neck dermatitis in patients on dupilumab therapy have added further complexity to diagnosis and management. Herein, we discuss a broad diagnostic algorithm and practical management strategy for recalcitrant face and neck dermatitis in the atopic patient with an emphasis on face and neck dermatitis associated with dupilumab therapy. Our aim is to raise awareness about the probable entity of drug-associated face and neck dermatitis and share a practical management strategy that may also be applied broadly to atopic dermatitis patients presenting with face and neck dermatitis.
Assuntos
Anticorpos Monoclonais Humanizados/efeitos adversos , Dermatite Alérgica de Contato/diagnóstico , Dermatite Atópica/tratamento farmacológico , Dermatite Perioral/diagnóstico , Dermatite Seborreica/diagnóstico , Dermatoses Faciais/diagnóstico , Rosácea/diagnóstico , Administração Cutânea , Algoritmos , Diagnóstico Diferencial , Gerenciamento Clínico , Dermatoses Faciais/etiologia , Glucocorticoides/efeitos adversos , Humanos , Hipersensibilidade Imediata/diagnóstico , Malassezia/imunologia , Infestações por Ácaros/diagnóstico , Pescoço , Guias de Prática Clínica como Assunto , Síndrome de Abstinência a Substâncias/diagnóstico , Síndrome de Abstinência a Substâncias/etiologiaRESUMO
BACKGROUND: Rosacea is a common chronic inflammatory cutaneous disorder affecting nearly 5.5 % of the adult population. Our aim was to evaluate the prevalence and epidemiology of rosacea and perioral dermatitis (POD) in an ambulatory care setting. METHODS: We retrospectively analyzed medical data of patients with a confirmed diagnosis of rosacea or perioral dermatitis (POD) presenting at our university hospital outpatient clinic during a 3-year period. RESULTS: Out of 1032 patients, 81.5 % were diagnosed with rosacea and 18.5 % with POD. Overall prevalence was 1.4 % for rosacea and 0.3 % for POD. 69.3 % of the analyzed patients were female. Overall mean age was 49.3 ± 7.7 (1-92) years; the women's average age was less than the men's. Patients with POD were younger and predominantly female, whereas patients with phymatous rosacea were older and predominantly male. The most common phenotypes were papulopustular rosacea (68.4 %), erythematotelangiectatic rosacea (22.5 %), and phymatous rosacea (8.0 %). Special forms of rosacea were diagnosed in 15.8 % of the patients; the most frequent were ocular rosacea (6.9 %) and steroid-induced rosacea (5.4 %). CONCLUSIONS: The large patient cohort analyzed in our study provides a good estimate of the frequency of the rosacea subtypes, special forms and of perioral dermatitis in a hospital-based outpatient care setting.
Assuntos
Dermatite Perioral/epidemiologia , Rosácea/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Alemanha/epidemiologia , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Adulto JovemRESUMO
BACKGROUND/OBJECTIVE: Skin diseases, especially those with visible manifestation, are considered to cause a major influence on global mental health. Therefore, we determined the prevalence and severity of anxiety, depression, and suicidal ideation in a large sample of patients with facial dermatoses, namely acne, rosacea, folliculitis, and perioral dermatitis. METHODS: The mental health of patients with facial dermatoses and respective controls was assessed using the Hospital Anxiety and Depression Scale and questions concerning suicidal ideation. RESULTS: The study included 543 patients with facial dermatoses and 497 healthy individuals. Anxiety was present in 37.6% of the patients (14.9% of controls), depression in 21.7% (6.8%), and suicidal thoughts in 9.8% (3.2%) (p < 0.001). Acne patients demonstrated the highest anxiety and depression subscale scores (mean ± standard deviation: 7.1 ± 0.25, 95% confidence interval (CI): 6.58-7.56; controls: 5 ± 0.23, 95% CI: 4.57-5.49). In rosacea 30% of the patients had depression symptoms (adjusted odds ratio (OR): 7.216, 95% CI: 4.122-12.632, p < 0.001), while in folliculitis patients 15.4% (OR: 3.138, 95% CI: 1.241-7.936, p = 0.016) had suicidal thoughts. Patients with anxiety symptoms and suicidal thoughts were on average younger than those without (28.3 ± 0.76 vs. 31.2 ± 0.66 years, p = 0.001 and 25.3 ± 0.98 vs. 30.5 ± 0.55 years, p = 0.007, respectively). CONCLUSION: Acne and rosacea are associated with anxiety, depression, and suicidal ideation in Lithuanian patients. Younger patients are more prone to report such symptoms than older ones.